Skip to main content
. 2015 Oct 1;25(8):611–617. doi: 10.1089/cap.2015.0075

FIG. 2.

FIG. 2.

Risk of anxiety in children with attention-deficit/hyperactivity disorder (ADHD) treated with psychostimulants compared with placebo. Meta-analysis demonstrated a significantly decreased risk of anxiety when comparing psychostimulant to placebo (relative risk [RR] = 0.86 [95% CI: 0.77, 0.95], z = −2.90, p = 0.004). There was no significant evidence of heterogeneity or publication bias.